- Sweden
- /
- Medical Equipment
- /
- OM:SDOS
At kr3.19, Is ScandiDos AB (publ) (STO:SDOS) Worth Looking At Closely?
ScandiDos AB (publ) (STO:SDOS), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the OM over the last few months, increasing to kr4.00 at one point, and dropping to the lows of kr3.19. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether ScandiDos' current trading price of kr3.19 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at ScandiDos’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
See our latest analysis for ScandiDos
What's the opportunity in ScandiDos?
The stock seems fairly valued at the moment according to my valuation model. It’s trading around 18% below my intrinsic value, which means if you buy ScandiDos today, you’d be paying a reasonable price for it. And if you believe that the stock is really worth SEK3.87, then there isn’t much room for the share price grow beyond what it’s currently trading. Although, there may be an opportunity to buy in the future. This is because ScandiDos’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.
Can we expect growth from ScandiDos?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With revenues expected to grow by 35% over the next couple of years, the future seems bright for ScandiDos. If the level of expenses is able to be maintained, it looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
What this means for you:
Are you a shareholder? It seems like the market has already priced in SDOS’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?
Are you a potential investor? If you’ve been keeping tabs on SDOS, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
If you want to dive deeper into ScandiDos, you'd also look into what risks it is currently facing. At Simply Wall St, we found 2 warning signs for ScandiDos and we think they deserve your attention.
If you are no longer interested in ScandiDos, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
About OM:SDOS
ScandiDos
Engages in the provision of measurement systems and software designed for the QA and validation of new dynamic and modulated treatments implemented in clinics worldwide.
Flawless balance sheet and good value.